Violation Tracker Individual Record
Company:Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.
Date:March 6, 2014
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Janssen agreed to pay $5.9 million in settlement of allegations it marketed its antipsychotic drug Risperdal for unapproved uses and hid dangers associated with the drug.
Level of Government:state
Action Type:agency action
Agency:Montana Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New Jersey
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.